Detecting circulating tumor cells

A proof-of-concept device is nearly perfect in separating breast cancer cells from blood.

About 1 in 4 deaths in the United States are due to cancer, but primary tumors are rarely fatal. Instead, it's when tumors metastasize that cancer becomes so deadly. To help patients and physicians make , teams of researchers have been working on various methods to detect cancer's spread – via the bloodstream – before secondary tumors develop. Now, one team reports a nearly perfect method for separating from blood. They describe their proof-of-concept device in a paper accepted for publication in Biomicrofluidics.

Detecting and separating (CTCs) is like finding the proverbial needle in a haystack: as few as one in a billion cells in a patient's bloodstream may be a CTC. Separation techniques vary widely, relying on differences in chemical, paramagnetic, or to distinguish CTCs from blood cells, or using mechanical sieves to cull the larger CTCs from the smaller blood cells. More recently, researchers have applied forces to fluid containing both and CTCs, using differences in inertia to sort cells. The technique, called "hydrodynamic sorting," is faster and easier than other sorting techniques. Like other mechanical techniques, it also allows researchers to collect viable cells after sorting them.

The team employed hydrodynamic sorting to develop their new device, called a multi-stage, multi-orifice flow fractionation (MS-MOFF) system. A previous design by the same team had just a single stage for applying hydrodynamic forces, but by adding an additional stage – so the output of the first stage becomes the input to the second stage – the researchers improved the separation efficiency of CTCs from 88.8% to 98.9%. Required pretreatment of the samples still makes MS-MOFF a proof-of-concept device, but the researchers suggest several ways to overcome such limitations and so make it useful for clinical applications.

More information: "Continual collection and re-separation of circulating tumor cells (CTCs) from blood using multi-stage multi-orifice flow fractionation," is published in Biomicrofluidics. bmf.aip.org/resource/1/biomgb/v7/i1/p014105_s1

add to favorites email to friend print save as pdf

Related Stories

Recommended for you

Endogenous hormones improve breast cancer risk models

7 hours ago

(HealthDay)—Inclusion of endogenous hormones in prediction models improves prediction of invasive breast cancer risk in postmenopausal women, according to a study published online Aug. 18 in the Journal of ...

Novel oncogenic RET mutation found in small cell lung cancer

8 hours ago

For the first time an oncogenic somatic mutation at amino acid 918 in the RET (rearranged during transfection) protein has been identified in small cell lung cancer (SCLC) tumors and enforced expression of this mutation within ...

User comments